Galmes Antonio, Gutiérrez Antonio, Sampol Antonia, Canaro Mariana, Morey Miguel, Iglesias Julio, Matamoros Nuria, Duran María Antonia, Novo Andrés, Bea María Dolores, Galán Pilar, Balansat Josep, Martínez Jordi, Bargay Joan, Besalduch Joan
Hematology Service and Bone Marrow Transplantation Unit, Immunology Service, University Hospital Son Dureta, Palma de Mallorca, Balearic Islands, Spain.
Haematologica. 2007 Jul;92(7):986-9. doi: 10.3324/haematol.11060.
We report the long-term evaluation over 12 years of a simplified technique for stem-cell cryopreservation at -80 degrees C without rate-controlled freezing and with 5% (n=251) or 10% (n=47) DMSO as the sole cryoprotectant. Platelet recovery was greater in the 5% DMSO group while long-term hematological recovery did not differ. Factors influencing a faster hematological recovery were infusion of more than 2.7x10(6)/Kg of CD34+ cells, 10% DMSO cryopreservation and G-CSF. We confirm that the procedure is feasible with reduction in infusion-related toxicity from 60% using 5% DMSO. Differences in hematological reconstitution were not clinically significant if a minimum of 1.5x10(6)/Kg CD34+-cells were infused.
我们报告了一项为期12年的长期评估,该评估针对一种简化的干细胞冷冻保存技术,该技术在-80摄氏度下进行,无需速率控制冷冻,仅使用5%(n = 251)或10%(n = 47)的二甲亚砜(DMSO)作为唯一的冷冻保护剂。5% DMSO组的血小板恢复情况更好,而长期血液学恢复情况并无差异。影响血液学更快恢复的因素包括输注超过2.7×10⁶/Kg的CD34⁺细胞、10% DMSO冷冻保存以及使用粒细胞集落刺激因子(G-CSF)。我们证实该程序是可行的,使用5% DMSO时与输注相关的毒性从60%有所降低。如果输注至少1.5×10⁶/Kg的CD34⁺细胞,血液学重建的差异在临床上并不显著。